Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Restaxil Komplex 26
- Development stage
- Unknown
- Lead developer
- PharmaSGP
- Administration
- Oral
01
Overview
Restaxil Komplex 26 is an oral multi-nutrient dietary supplement developed by PharmaSGP. It is formulated as a powder for oral solution (nutrient drink) containing a combination of 26 micronutrients, including choline, N-acetyl-L-carnitine, vitamins (such as B-complex, C, D, E, and K), and minerals (such as magnesium, potassium, copper, and zinc). The supplement is specifically designed to support the normal function of the nervous system and promote healthy nerve regeneration by providing essential components for the maintenance and structure of the myelin sheath.
- Brand names
- Restaxil Komplex 26
- Other names
- Restaxil Complex 26Restaxil Komplex 26 Pulver
Beyond the preview
Go deeper on Restaxil Komplex 26.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Restaxil Komplex 26.